SEMIN THROMB HEMOST
| WoS 期刊 JCR 分区 (2026 · JIF) | 综合 SCIE | Q1 | ||
|---|---|---|---|---|
| 学科 | 收录集 | JIF 分区 | JIF 排名 | JIF 百分位 |
| 周围血管疾病 Peripheral Vascular Disease | SCIE | Q1 | 23/100 |
77.0%
|
| 血液学 Hematology | SCIE | Q1 | 24/103 |
76.7%
|
| 学科 | 收录集 | JCI 分区 | JCI 排名 | JCI 百分位 |
|---|---|---|---|---|
| 周围血管疾病 Peripheral Vascular Disease | SCIE | Q1 | 23/92 JCI 0.84 |
76.1%
|
| 血液学 Hematology | SCIE | Q2 | 25/87 JCI 0.84 |
72.4%
|
Seminars in Thrombosis and Hemostasis (SEMIN THROMB HEMOST) is a peer-reviewed medical journal dedicated to advancing the understanding and clinical management of thrombotic and bleeding disorders. Published by Thieme Medical Publishers, the journal provides in-depth, focused coverage of hemostasis, coagulation, fibrinolysis, platelet function, and vascular biology. Its scope encompasses both fundamental research and practical clinical applications, with particular emphasis on thrombosis, anticoagulant therapy, hemorrhagic diseases, and laboratory diagnostics. The journal primarily publishes invited review articles and state-of-the-art thematic issues, each curated by expert guest editors, though original research and case reports are also considered. Each issue typically centers on a specific topic, offering a comprehensive synthesis of current knowledge, emerging therapies, and diagnostic challenges. The target audience includes hematologists, vascular medicine specialists, pathologists, clinical laboratory scientists, and researchers in coagulation and thrombosis. Notably, the journal operates under a traditional subscription model with select open access options available through author choice. With a 2026 Impact Factor of 4.200 and a JCR Quartile ranking of Q1 in its category, Seminars in Thrombosis and Hemostasis is recognized as a leading authoritative resource in the field. Its consistently high impact factor and top-tier quartile placement underscore its significant influence on both clinical practice and translational research, making it an essential reference for professionals seeking rigorous, expert-driven syntheses of complex hemostatic and thrombotic topics.